Navigation Links
Echo Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference
Date:6/3/2011

PHILADELPHIA, June 3, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., CEO, President and Chairman of the Board of Echo Therapeutics will present at the Jefferies 2011 Global Healthcare Conference.

Dr. Mooney will make a corporate presentation to prospective corporate partners and investors on Wednesday, June 8th at 8:30 AM ET in New York City.

About Echo TherapeuticsEcho is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals. For More Information:Patrick T. Mooney, M.D.

Media: Richard SternChairman and Chief Executive Officer

Stern & Co.(215) 717-4100

(212) 888-0044
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Orexigen® Therapeutics Provides a Regulatory Update on Contrave® NDA
2. Goodwin Biotechnology Announces a Collaboration With Alethia Biotherapeutics
3. Serina Therapeutics, Inc. Closes $9.5 Million Financing Round
4. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
5. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
6. Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017
7. Reportlinker Adds Myelodysplastic Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017
8. Cell Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Rule
9. Amicus Therapeutics to Present at Jefferies 2011 Global Healthcare Conference on Tuesday, June 7, 2011
10. Reportlinker Adds Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
11. Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... New Jersey , May 4, 2016 ... its successful completion of an alternative public offering (APO). ... wholly owned operating company, Valeritas, Inc. and a private ... common stock at $5.00 per share. Under ... on May 3, 2016, Valeritas Holdings, Inc. will trade ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Actinic Keratosis Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Competitive Landscape Highlights 2016, provides comprehensive insights ... epidemiology, Actinic Keratosis market valuations and forecast, ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology:
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... A new ... the world. The Duke Clinical Research Institute (DCRI) and analytics leader SAS will provide ... patient data collected by the Duke University Health System. , The DCRI and ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... 2016. SS&A teamed up with one of the top website design companies to ... contains informative legal articles related to the law firm's main practice areas. These ...
(Date:5/4/2016)... NC (PRWEB) , ... May 04, 2016 , ... Francesca ... N.C., changed her life forever with a same-day LASIK procedure at Christenbury ... poor eyesight. Dr. Jonathan Christenbury performed her surgery the same day as her in-office ...
(Date:5/4/2016)... ... 04, 2016 , ... Advanced Spine & Sport Medical Rehabilitation Center, which is ... hosting a free seminar on stem cell injections. The seminar is scheduled for Wednesday, ... 4601 Telephone Road, Suite 110, Ventura, CA. There are only 10 seats available. ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... powerful cellular therapy software application that helps blood and marrow transplant (BMT) programs ... Transtem’s initial launch, Mediware has continued to enhance core application features. These enhancements ...
Breaking Medicine News(10 mins):